10-Q Filing

CVS HEALTH CORP CIK: 64803 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0000064803-23-000033`
Period End Date	20230630
Filing Date	20230802
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	cvs-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 108 Income Statement 94 Cash Flow Statement 92 Stockholders Equity 63 Comprehensive Income 44

Balance Sheet 108 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.95B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.81B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.78B	USD	Point-in-time
Investments	`ShortTermInvestments`	$3.08B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$27.28B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$29.55B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$17.29B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$19.09B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$908.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$620.00M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.64B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.41B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$65.63B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$67.76B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.28B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	482.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$21.10B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$22.11B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.87B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.00B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.87B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.70B	USD	Point-in-time
Goodwill	`Goodwill`	$78.15B	USD	Point-in-time
Goodwill	`Goodwill`	$91.26B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.80B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.27B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.23B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.85B	USD	Point-in-time
Total assets	`Assets`	$228.28B	USD	Point-in-time
Total assets	`Assets`	$250.07B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$14.84B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$13.37B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$19.42B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$20.42B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$12.00B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.14B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.50B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.41B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$18.75B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$22.83B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$4.87B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.09B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.71B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.68B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	-	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.00B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.40B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.78B	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$208.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$228.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.42B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$79.21B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.80B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.61B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$61.42B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$50.48B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.59B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.02B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.23B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$5.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.27B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.14B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.66B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.83B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.32B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$177.07B	USD	Point-in-time
Total liabilities	`Liabilities`	$156.51B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,764 shares issued and 1,282 shares outstanding at June 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.65B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,764 shares issued and 1,282 shares outstanding at June 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.19B	USD	Point-in-time
Treasury stock, at cost: 482 shares at June 30, 2023 and 458 shares at December 31, 2022	`TreasuryStockCommonValue`	$33.93B	USD	Point-in-time
Treasury stock, at cost: 482 shares at June 30, 2023 and 458 shares at December 31, 2022	`TreasuryStockCommonValue`	$31.86B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$58.87B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$56.40B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.26B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-858.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$72.73B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$71.47B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$276.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$300.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.74B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.00B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$250.07B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$228.28B	USD	Point-in-time

Income Statement 94 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$25.11B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$21.26B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$42.89B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$49.46B	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$608.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$274.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$314.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$146.00M	USD	1 Quarter
Total revenues	`Revenues`	$88.92B	USD	1 Quarter
Total revenues	`Revenues`	$157.46B	USD	2 Qtrs
Total revenues	`Revenues`	$80.64B	USD	1 Quarter
Total revenues	`Revenues`	$174.20B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$104.99B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$53.54B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$49.29B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$94.80B	USD	2 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$35.41B	USD	2 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$42.23B	USD	2 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$17.49B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$21.78B	USD	1 Quarter
Restructuring charge	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	1 Quarter
Restructuring charge	`RestructuringCostsAndAssetImpairmentCharges`	$496.00M	USD	1 Quarter
Restructuring charge	`RestructuringCostsAndAssetImpairmentCharges`	$496.00M	USD	2 Qtrs
Restructuring charge	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	2 Qtrs
Opioid litigation charge	`GainLossRelatedToLitigationSettlement`	$-484.00M	USD	2 Qtrs
Opioid litigation charge	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Opioid litigation charge	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Opioid litigation charge	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$41.00M	USD	2 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$349.00M	USD	2 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$18.51B	USD	2 Qtrs
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.19B	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$19.45B	USD	2 Qtrs
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.87B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$167.52B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$149.25B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$75.97B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$85.69B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.21B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$6.68B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$3.23B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$4.67B	USD	1 Quarter
Interest expense	`InterestExpense`	$1.27B	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.17B	USD	2 Qtrs
Interest expense	`InterestExpense`	$583.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$686.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$44.00M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$43.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$85.00M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$22.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.45B	USD	2 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.13B	USD	2 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.57B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.13B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.74B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$656.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.39B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$1.09B	USD	1 Quarter
Net income	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income	`ProfitLoss`	$4.06B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income	`ProfitLoss`	$5.39B	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$10.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$19.00M	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$4.04B	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$1.90B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$5.38B	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$3.03B	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.31	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.10	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.48	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.15	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.13	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.48	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.29	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.06	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.28B	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.28B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.29B	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.29B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.60	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.55	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.10	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.21	USD	2 Qtrs

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$175.57B	USD	2 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$151.77B	USD	2 Qtrs
Cash paid for prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$90.89B	USD	2 Qtrs
Cash paid for prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$101.32B	USD	2 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$33.92B	USD	2 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$41.11B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$15.12B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$17.69B	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$801.00M	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$200.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.13B	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.15B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.78B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.89B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.01B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.35B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$4.36B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.64B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$5.01B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$4.50B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.46B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.57B	USD	2 Qtrs
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$125.00M	USD	2 Qtrs
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$16.47B	USD	2 Qtrs
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,807 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.94B	USD	2 Qtrs
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,807 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-54.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-32.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.12B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-18.88B	USD	2 Qtrs
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	$1.00B	USD	2 Qtrs
Commercial paper borrowings (repayments), net	`ProceedsFromRepaymentsOfCommercialPaper`	-	USD	2 Qtrs
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	$5.00B	USD	2 Qtrs
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	-	USD	2 Qtrs
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	$5.00B	USD	2 Qtrs
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$10.90B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.79B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.53B	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.02B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.57B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.46B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$348.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$120.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$168.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$329.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-121.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-139.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.11B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.35B	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-228.00M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$822.00M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.46B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.46B	USD	Point-in-time
Net income	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income	`ProfitLoss`	$4.06B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income	`ProfitLoss`	$5.39B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.10B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.13B	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$307.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$236.00M	USD	2 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	$225.00M	USD	2 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	2 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	$225.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$87.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$-246.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$804.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.69B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.80B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-469.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$913.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$286.00M	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-118.00M	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.03B	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$1.29B	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$4.33B	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$901.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.49B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.01B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.35B	USD	2 Qtrs

Stockholders Equity 63 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	482.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.74B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.00B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$4.06B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.39B	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$389.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-540.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$17.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$406.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-763.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.30B	USD	2 Qtrs
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$122.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$345.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$300.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$197.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$267.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$129.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.96B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.97B	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$781.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$730.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$729.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$786.00M	USD	1 Quarter
Acquisition of noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$66.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-5.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-99.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	482.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.74B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.00B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time

Comprehensive Income 44 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income	`ProfitLoss`	$4.06B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income	`ProfitLoss`	$5.39B	USD	2 Qtrs
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-2.00B	USD	2 Qtrs
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-865.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-64.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$406.00M	USD	2 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$60.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$-14.00M	USD	2 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$310.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$679.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00M	USD	2 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$19.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$12.00M	USD	2 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$15.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$13.00M	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$389.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-540.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$17.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$406.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-763.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.30B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.09B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.93B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.46B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.50B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$10.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$19.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$4.08B	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.92B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$4.44B	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.49B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.